AAAAAA
Results:
1-14
|
Results: 14
Authors:
Wilcox, LJ
Borradaile, NM
de Dreu, LE
Huff, MW
Citation: Lj. Wilcox et al., Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP, J LIPID RES, 42(5), 2001, pp. 725-734
Authors:
Hegele, RA
Huff, MW
Young, TK
Citation: Ra. Hegele et al., Common genomic variation in LMNA modulates indexes of obesity in Inuit, J CLIN END, 86(6), 2001, pp. 2747-2751
Authors:
Spence, JD
Munoz, C
Huff, MW
Tokmakjian, S
Citation: Jd. Spence et al., Effect of amlodipine on hemodynamic and endocrine responses to mental stress, AM J HYPERT, 13(5), 2000, pp. 518-522
Authors:
Wolfe, BM
Barrett, PHR
Laurier, L
Huff, MW
Citation: Bm. Wolfe et al., Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women, J LIPID RES, 41(3), 2000, pp. 368-375
Authors:
Hegele, RA
Cao, HN
Huff, MW
Anderson, CM
Citation: Ra. Hegele et al., LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration, J CLIN END, 85(9), 2000, pp. 3089-3093
Authors:
Cheung, R
Lewanczuk, RZ
Rodger, NW
Huff, MW
Oddou-Stock, P
Botteri, F
Pecher, E
Muirhead, N
Citation: R. Cheung et al., The effect of valsartan and captopril on lipid parameters in patients withtype II diabetes mellitus and nephropathy, INT J CL PR, 53(8), 1999, pp. 584
Authors:
Whitman, SC
Hazen, SL
Miller, DB
Hegele, RA
Heinecke, JW
Huff, MW
Citation: Sc. Whitman et al., Modification of type IIIVLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity,causes marked cholesteryl ester accumulation in macrophages, ART THROM V, 19(5), 1999, pp. 1238-1249
Authors:
Wilcox, LJ
Barrett, PHR
Newton, RS
Huff, MW
Citation: Lj. Wilcox et al., ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011 - An effect associated with enhanced intracellular degradation of ApoB, ART THROM V, 19(4), 1999, pp. 939-949
Authors:
Burnett, JR
Wilcox, LJ
Telford, DE
Kleinstiver, SJ
Barrett, PHR
Newton, RS
Huff, MW
Citation: Jr. Burnett et al., Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoproteinB production in miniature pigs, J LIPID RES, 40(7), 1999, pp. 1317-1327
Authors:
Whitman, SC
Argmann, CA
Sawyez, CG
Miller, DB
Hegele, RA
Huff, MW
Citation: Sc. Whitman et al., Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma, J LIPID RES, 40(6), 1999, pp. 1017-1028
Authors:
Wilcox, LJ
Barrett, PHR
Huff, MW
Citation: Lj. Wilcox et al., Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin, J LIPID RES, 40(6), 1999, pp. 1078-1089
Authors:
Burnett, JR
Wilcox, LJ
Telford, DE
Kleinstiver, SJ
Barrett, PHR
Newton, RS
Huff, MW
Citation: Jr. Burnett et al., The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs, ENDOCRINOL, 140(11), 1999, pp. 5293-5302
Authors:
Burnett, JR
Wilcox, LJ
Huff, MW
Citation: Jr. Burnett et al., Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion, CLIN CHIM A, 286(1-2), 1999, pp. 231-242
Authors:
Burnett, JR
Barrett, PHR
Vicini, P
Miller, DB
Telford, DE
Kleinstiver, SJ
Huff, MW
Citation: Jr. Burnett et al., The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs, ART THROM V, 18(12), 1998, pp. 1906-1914
Risultati:
1-14
|